Early Inflammatory Bowel Disease Progression
Recruiting · NCT06756100 · Observational (researchers observe without assigning treatment) · Lead sponsor: Pontificia Universidad Catolica de Chile
View the official record on ClinicalTrials.gov →What this trial is about
The purpose of this study is to assess the capacity of the gut microbial composition and function to predict the course of IBD during the first year after diagnosis.
Who can take part
Age range
18 Years to 100 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Adult patients with with at least 3 weeks of gastrointestinal symptoms including diarrhea, rectal bleeding, abdominal pain, tenesmus or urgency
Exclusion criteria
- Confirmed infectious disease of the gastrointestinal tract
Where it is running
2 locations listed.
- Pontificia Universidad Catolica of Chile - Santiago, Chile
- Pontificia Universidad Catolica of Chile - Santiago, Chile